The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

28 articles for D Ekinci


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.EBI
Jamia Hamdard (Hamdard University)
Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives.EBI
Balikesir University
Carbonic anhydrase inhibitors: Design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives.EBI
Gebze Technical University
Synthesis and carbonic anhydrase inhibitory properties of novel uracil derivatives.EBI
Agriibrahim£E£En University
Synthesis of 1,4-bis(indolin-1-ylmethyl)benzene derivatives and their structure-activity relationships for the interaction of human carbonic anhydrase isoforms I and II.EBI
Karamanoglu Mehmetbey University
Purification and characterization of carbonic anhydrase from sheep kidney and effects of sulfonamides on enzyme activity.EBI
Agri Ibrahim Cecen University
Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors.EBI
Batman University
Characterization and anions inhibition studies of ana-carbonic anhydrase from the teleost fish Dicentrarchus labrax.EBI
Ondokuz Mayis University
In vitro inhibition of human erythrocyte glutathione reductase by some new organic nitrates.EBI
Ataturk University
Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.EBI
Ondokuz Mayis University
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.EBI
University of Calgary
A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies.EBI
Ataturk University
NO-releasing esters show carbonic anhydrase inhibitory action against human isoforms I and II.EBI
Ataturk University
Dihydrofolate reductase inhibitorsBDB
Trius Therapeutics
PyrazoloquinolinesBDB
Merck Patent
Apoptosis signal-regulating kinase 1 inhibitorsBDB
Takeda Pharmaceutical
Synthesis of (glycopyranosyl-triazolyl)-purines and their inhibitory activities against protein tyrosine phosphatase 1B (PTP1B).BDB
East China University of Science and Technology
5-lipoxygenase-activating protein inhibitorBDB
Panmira Pharmaceuticals
Amine substituted methanesulfonamide derivatives as vanilloid receptor ligandsBDB
Gruenenthal
PDE10 modulatorsBDB
Hoffmann-La Roche
Fused 2-aminothiazole compoundsBDB
Dana-Farber Cancer Institute
Synthesis and evaluation of novel marine bromopyrrole alkaloid-based derivatives as potential antidepressant agents.BDB
University of Kwazulu-Natal
Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.BDB
Y.B. Chavan College of Pharmacy
7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereofBDB
Theron Pharmaceuticals
Inhibitors of PI3 kinaseBDB
Amgen
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models.BDB
Abbott Laboratories